Skip to main content

Table 1 Prevalence of chronic hepatitis B and coverage of expanded program on HBV immunization in Asian countries receiving a high number of travelers [10, 12, 14]

From: Hepatitis B vaccination for international travelers to Asia

Arrival Country

International traveler’s arrivals per year (2014)

Estimated prevalence of chronic hepatitis B infectiona

Estimated HBsAg positive population

Implement of Expanded program of immunization (EPI) for HBV (Year)

Complete HBV vaccination at year 2014 (%)

Population age after EPI deployed at year 2016

China

55,622,000

5.49 %

74,601,204

2000

99

16

Malaysia

27,437,000

0.74 %

208,540

1989

96

27

Thailand

24,780,000

6.42 %

4,260,008

1992

99

24

Saudi Arabia

15,098,000

3.18 %

866,675

1990

98

26

South Korea

14,202,000

4.36 %

2,111,914

1995

99

21

Japan

13,413,000

1.02 %

1,294,431

No

No

0

Singapore

11,858,000

4.09 %

207,943

1990

97

26

Indonesia

9,435,000

1.86 %

4,468,684

1992

78

24

India

7,703,000

1.46 %

17,553,389

2004

70

12

Vietnam

7,874,000

10.79 %

9,607,438

2003

95

13

Philippines

4,833,000

4.63 %

4,326,212

1995

79

21

Cambodia

4,503,000

4.05 %

581,596

2006

97

10

Jordan

3,990,000

1.86 %

119,919

1995

98

18

Myanmar

3,081,000

3.40 %

1,765,643

2003

75

13

Laos

2,510,000

8.74 %

558,710

2003

88

13

  1. Estimated at year 2015 based on data on prevalence of chronic HBV infection published between Jan 1, 1965, and Oct 23, 2013a